Authors
Latest:
Palliative Care for Young Adults Is a Growing Reality in CRCAlthough most younger patients received diagnoses of cancer of the rectum or distal colon, incidence rates are increasing across all colorectal anatomic subsites.
Latest:
Future Outlooks in the Treatment of R/R DLBCLShared insight on the future of diffuse large B-cell lymphoma management, highlighting unmet needs and hope for continued growth in the treatment landscape.
Latest:
Case Studies with Hepatic Artery InfusionRyan Merkow, MD, MS, and Louise Catherine Connell, MB BCh BAO, BMedSc, review cases of patients with colorectal cancer and provide insights on clinical practice.
Latest:
Dr Lee on Head and Neck Cancer Updates from the 2024 ACRO SummitAnna Lee, MD, MPH, discusses key takeaways from a presentation on managing head and neck cancers that was given at the 2024 ACRO Summit.
Latest:
Addressing Treatment Gaps in HER2+ MBCUnmet needs regarding the selection and sequencing of therapies for patients with HER2-positive metastatic breast cancer.
Latest:
Dr Epstein-Peterson on the Use of CAR T-Cell Therapy in MCLZachary Epstein-Peterson, MD, discusses the use of CAR T-cell therapy in mantle cell lymphoma and highlights questions that remain to be answered within the treatment landscape.
Latest:
Dr D’Amico on the Nuances of a Low Gleason Score in Localized Prostate CancerAnthony V. D'Amico, MD, PhD, discusses Gleason score interpretation in the management of localized prostate cancer.
Latest:
Dr Johnson the Accuracy of Genomic Testing in Black Women With ER+ Breast CancerNathalie McDowell Johnson, MD, FACS, discusses the accuracy of genomic testing in Black women with estrogen receptor-positive breast cancer.
Latest:
Demystifying the Role of Palliative Care in the Oncology ClinicDespite American Society of Clinical Oncology guidelines calling for introduction of palliative care early in the course of disease, these services remain underused.
Latest:
Taking Organoids From Bench to Bedside Through Endoscopy in Pancreatic Cancer: Ongoing ResearchIn this seventh episode of OncChats: Taking Organoids From Bench to Bedside Through Endoscopy in Pancreatic Cancer, Toufic A. Kachaamy, MD, Madappa Kundranda, MD, PhD, and Richard Burkhart, MD, discuss ongoing research such as the PASS-01 trial (NCT04469556) in pancreatic cancer and ways to translate advances in the metastatic setting to the curative setting.
Latest:
Final Thoughts on CSPCExperts offer concluding remarks on castration-sensitive prostate cancer, sharing their perspectives on the evolving field and expressing their aspirations for future advancements in disease treatment.
Latest:
Dr Garcia on the Future of the MELISA Trial in Ovarian CancerNúria Agustí Garcia, MD, discusses the mapping of sentinel lymph nodes in early-stage ovarian cancer.
Latest:
Dr. Kato on the Rationale For Investigating Dato-DXd Plus Durvalumab and Carboplatin in Advanced NSCLCTerufumi Kato, MD, Terufumi Kato, MD, Chief Physician, Department of Thoracic Oncology, Kanagawa Cancer Center, Yokohama, Japan, discusses the ongoing investigation of datopotamab deruxtecan in combination with durvalumab and carboplatin as a first-line treatment for patients with advanced metastatic non–small cell lung cancer.
Latest:
Dr Pagliaro on the Use of First-Line Avelumab Maintenance Therapy in Urothelial CarcinomaLance C. Pagliaro, MD, discusses the efficacy of first-line avelumab maintenance therapy, as seen in the phase 3 JAVELIN Bladder 100 trial in patients with advanced urothelial carcinoma.
Latest:
Dr. Pederson on the Importance of Ancestrally-Unbiased Polygenic Risk Assessment in Breast CancerHolly Pederson, MD, discusses the importance of ancestrally-unbiased polygenic risk assessment in patients with breast cancer.
Latest:
Dr Mehta on Risks of CAR T-cell Therapy in Heavily Pretreated Lymphoma PatientsAmitkumar Mehta, MD, discusses CAR T-cell therapy-associated risks in patients with lymphoma who have undergone multiple lines of prior chemotherapy.
Latest:
Experts Discuss the Management of Paronychia When Treating Patients with EGFR TKIsZosia Piotrowska, MD, Christine Lovly, MD, PhD, and Amanda Cass, PharmD, BCPS, BCOP, discuss the management of paronychia when treating patients with EGFR TKIs.
Latest:
Dr Hu on the Evaluation of Tibremciclib Plus Fulvestrant in HR+/HER2– Advanced Breast CancerXichun Hu, MD, PhD, discusses a study of tibremciclib plus fulvestrant in HR+/HER2– advanced breast cancer following progression on endocrine therapy.
Latest:
Optimizing the Selection of Novel Therapy for Patients With Advanced NSCLCClosing out their panel on immunotherapy in non–small cell lung cancer, expert oncologists share key takeaways on the selection of novel therapy in this setting.
Latest:
The Podcast by Fellows for FellowsDaniel J. Hausrath, MD, discusses a collaborative effort to produce a podcast for fellows that reviews the fundamentals, core concepts, and important management approaches in the field, as determined by the latest evidence and expert opinion.
Latest:
Dr. DeCesaris on Classical vs Contemporary Indications for Radiation in Breast CancerCristina DeCesaris, MD, discusses classical indications for breast cancer radiation and how these methods are being contextualized in the contemporary treatment era.
Latest:
Dr. Greene on the Future of Personalized Therapy in Prostate CancerKirsten L. Greene, MD, MAS, FACS, discusses the future of personalized therapy in prostate cancer.
Latest:
Treatment Landscape Shifts Away From Chemotherapy Toward Targeted Approaches in ALLNovel approaches with highly active, minimally toxic agents are needed to improve upon traditional chemotherapy and possibly eliminate chemotherapy altogether in the treatment of patients with acute lymphoblastic leukemia.
Latest:
Student Loan Debt, Immigration Status Often Drive Career Decisions for FellowsInvestigators from Indiana University decided to study some of the factors influencing career plans for physicians, focusing on current fellows and recent graduates of the hematology and medical oncology specialty in the United States.
Latest:
Holistic and Multidisciplinary Approaches to Multiple Myeloma ManagementClosing out their program on multiple myeloma, expert panelists consider the role of holistic and multidisciplinary care when managing patients within the current paradigm.
Latest:
Dr Alfonso Piérola on Unmet Needs in Higher-Risk MDSAna Alfonso Piérola, MD, PhD, discusses unmet needs for patients with high-risk myelodysplastic syndrome.
Latest:
MRD and ctDNA Could Shift into Larger Role to Guide Treatment Decisions in Breast CancerPraveen Vikas, MBBS, discusses what is currently known regarding minimal residual disease testing in breast cancer, expanded on what still needs to be done to bring minimal residual disease and ctDNA testing to clinical practice, and highlighted the evolving treatment paradigm for patients with advanced hormone receptor-positive, HER2-negative breast cancer.
Latest:
Dr. Frigault on Toxicity Differences Among CAR T-Cell Products in Leukemias, LymphomasMatthew Frigault, MD, discusses differences in the toxicities experienced with CAR T-cell products used in the treatment of patients with leukemias and lymphomas.
Latest:
Dr Rodriguez on the Use of HER2-Directed Therapies in NSCLCEstelamari Rodriguez, MD, MPH, discusses adverse effects associated with HER2-directed antibody-drug conjugates in non–small cell lung cancer.
.jpg?fit=crop&auto=format)
